Aaron Royston - 20 Oct 2021 Form 3/A - Amendment Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Director
Signature: /s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol: VTYX
Transactions as of: 20 Oct 2021
Transactions value $: $0
Form type: 3/A - Amendment
Filing time: 14 Sep 2022, 17:00:49 UTC
Date Of Original Report: 20 Oct 2021
Next filing: 25 Oct 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

This amendment to Form 3 is being filed to correctly report that the Reporting Person does not beneficially own any of the Issuer's securities held directly by venBio SPV III, LLC or venBio Global Strategic Fund III, L.P. Such shares were inadvertently included in the Form 3 filed by the Reporting Person on October 20, 2021 and the Form 4 filed by the Reporting Person on October 25, 2021.